Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sana Biotechnology Inc
(NQ:
SANA
)
7.730
-0.530 (-6.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,882,326
Open
8.200
Bid (Size)
7.600 (2)
Ask (Size)
7.700 (89)
Prev. Close
8.260
Today's Range
7.640 - 8.200
52wk Range
2.745 - 12.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
March 04, 2024
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
+84.05%
+84.05%
1 Month
-10.64%
-10.64%
3 Month
+36.81%
+36.81%
6 Month
+158.53%
+158.53%
1 Year
+38.28%
+38.28%
More News
Read More
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Sana Biotechnology Shares Are Rising Today
January 05, 2024
Via
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Via
Benzinga
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 29, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
February 28, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
February 13, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 12, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
PayPal Reports Q4 Results, Joins Rapid7, GoPro And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sana Biotechnology Announces Pricing of Upsized Public Offering
February 08, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 07, 2024
Via
Benzinga
Sana Biotechnology Announces Proposed Public Offering of Common Stock
February 07, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 12, 2024
Via
Benzinga
Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
January 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
January 05, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting
December 11, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 04, 2023
Via
Benzinga
Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
December 01, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 04, 2023
Via
Benzinga
Sana Biotechnology to Present at November and December 2023 Investor Conferences
November 21, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
November 17, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.